CTRI/2009/091/000582已完成1 期
An open-label, single-sequence pharmacokinetic study inhealthy subjects to assess the potential of AEB071 toinhibit and induce CYP1A2 using caffeine as a probesubstrate
ovartis Healthcare Pvt. Ltd.0 个研究点目标入组 18 人开始时间: 待定最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 18
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Non-smokers
- •Age: 18 to 45 years
- •Good health conditions
- •Post-menopausal or surgically sterilised females
排除标准
- •Use of any prescription drugs within 4weeks prior to dosing.
- •Donation or loss of 400ml or more blood.
- •Significant illness subjects.
- •No significant ECG abnormalities.
- •History of immunodefficiency disease.
研究者
相似试验
已完成
不适用
Bio availability study of Mangiferin from polyherbal formulatioCTRI/2014/01/004271SRM University10
尚未招募
不适用
Bio availability study of Berberine in Manasamitra Vatakam: An ayurvedic herbomineral formulatioCTRI/2020/02/023267SRM Institute of Science and Technology
已完成
1 期
A study to investigate the safety, tolerability and activity of IPP-201101 in healthy volunteersSystemic lupus erythematosus (SLE)Musculoskeletal DiseasesSystemic lupus erythematosusISRCTN16878305ImmuPharma S.A16
已完成
1 期
H8H-MC-LAHXMigraineJPRN-jRCT2080224864Eli Lilly Japan K.K.21
进行中（未招募）
不适用
An open label, single dose, pharmacokinetic study of oromucosal midazolam administered to children from 3 months to less than 18 years undergoing routine elective surgery - Midazolam PKIn the context of the trial, the IMP is to be used as anaesthetic premedication in children undergoing elective routine surgery.(The medical condition for marketing is acute seizures in children aged 3 months - <18 years.)MedDRA version: 9.1Level: LLTClassification code 10058073Term: Anaesthetic premedicationEUCTR2009-012808-11-DETherakind Limited75